Bitter pills for drug companies.
Newman
Melanie
M
Bureau of Investigative Journalism, City University, London EC1V7HD, UK. melanienewman@tbij.com
D000081:Acetamides / Q000191:economics; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D005607:Fraud / Q000191:economics / Q000331:legislation & jurisprudence; D007555:Isoxazoles / Q000191:economics; D000069349:Linezolid; D009042:Motivation; D056687:Off-Label Use / Q000191:economics / Q000331:legislation & jurisprudence*; D023303:Oxazolidinones / Q000191:economics; D010879:Piperazines / Q000191:economics; D000069583:Pregabalin; D013449:Sulfonamides / Q000191:economics; D013844:Thiazoles / Q000191:economics; D014481:United States; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000191:economics; D000096926:Benzenesulfonamides
D000081:Acetamides; D007555:Isoxazoles; D000069349:Linezolid; D023303:Oxazolidinones; D010879:Piperazines; D000069583:Pregabalin; D013449:Sulfonamides; D013844:Thiazoles; D005680:gamma-Aminobutyric Acid; C406224:valdecoxib; D000096926:Benzenesulfonamides; C092292:ziprasidone